Published in Int Arch Allergy Immunol on September 19, 2008
Immunomodulatory gene therapy prevents antibody formation and lethal hypersensitivity reactions in murine pompe disease. Mol Ther (2009) 1.34
The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice. Clin Exp Allergy (2012) 1.06
Cross-reactivity of peanut allergens. Curr Allergy Asthma Rep (2014) 0.86
Heterogeneous responses and cross reactivity between the major peanut allergens Ara h 1, 2,3 and 6 in a mouse model for peanut allergy. Clin Transl Allergy (2015) 0.84
Pepsinized cashew proteins are hypoallergenic and immunogenic and provide effective immunotherapy in mice with cashew allergy. J Allergy Clin Immunol (2012) 0.82
B cells establish, but do not maintain, long-lived murine anti-peanut IgE(a). Clin Exp Allergy (2016) 0.78
Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice. Mol Nutr Food Res (2013) 0.77
Prolonged Treatment of Peanut-Allergic Mice with Bortezomib Significantly Reduces Serum Anti-Peanut IgE but Does Not Affect Allergic Symptoms. Int Arch Allergy Immunol (2016) 0.75
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol (2009) 3.91
Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol (2010) 3.49
A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol (2008) 3.19
National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol (2010) 3.12
Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol (2006) 3.03
Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med (2003) 3.00
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98
Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol (2012) 2.90
A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol (2011) 2.77
X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) (2006) 2.66
The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol (2010) 2.52
The changing CARE for patients with food allergy. J Allergy Clin Immunol (2013) 2.04
Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol (2009) 1.98
Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants. J Allergy Clin Immunol (2010) 1.97
The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol (2012) 1.96
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol (2011) 1.93
The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol (2011) 1.81
The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol (2006) 1.79
Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol (2004) 1.68
Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol (2012) 1.56
Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol (2009) 1.53
Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol (2009) 1.50
The natural progression of peanut allergy: Resolution and the possibility of recurrence. J Allergy Clin Immunol (2003) 1.49
Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics (2012) 1.48
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol (2011) 1.30
Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. J Allergy Clin Immunol (2010) 1.25
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol (2013) 1.24
Safety of open food challenges in the office setting. Ann Allergy Asthma Immunol (2008) 1.24
Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta. Proc Natl Acad Sci U S A (2008) 1.22
Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity. Clin Immunol (2005) 1.21
Peanut allergy: recurrence and its management. J Allergy Clin Immunol (2004) 1.16
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res (2011) 1.14
Protein structure plays a critical role in peanut allergen stability and may determine immunodominant IgE-binding epitopes. J Immunol (2002) 1.12
Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol (2006) 1.11
Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol (2011) 1.11
Allergenic characteristics of a modified peanut allergen. Mol Nutr Food Res (2005) 1.09
Diacylglycerol kinase zeta regulates microbial recognition and host resistance to Toxoplasma gondii. J Exp Med (2007) 1.08
Soy immunotherapy for peanut-allergic mice: modulation of the peanut-allergic response. J Allergy Clin Immunol (2004) 1.07
Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol (2003) 1.07
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol (2013) 1.06
Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol (2010) 1.05
IgE-mediated food allergy in children. Lancet (2013) 1.03
Factors affecting the determination of threshold doses for allergenic foods: how much is too much? J Allergy Clin Immunol (2002) 1.01
Oral immunotherapy for food allergy. Curr Allergy Asthma Rep (2009) 0.98
A neonatal swine model for peanut allergy. J Allergy Clin Immunol (2002) 0.97
Pathophysiology of food allergy. Pediatr Clin North Am (2011) 0.95
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. J Allergy Clin Immunol (2012) 0.94
Egg oral immunotherapy in non-anaphylactic children with egg allergy: follow-up. J Allergy Clin Immunol (2007) 0.94
Clinical characteristics of peanut-allergic children: recent changes. Pediatrics (2007) 0.93
Monitoring peanut allergen in food products by measuring Ara h 1. J Allergy Clin Immunol (2003) 0.93
Peanut allergenicity. Ann Allergy Asthma Immunol (2004) 0.92
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition (2011) 0.92
Oral and sublingual immunotherapy for food allergy: current progress and future directions. Curr Opin Immunol (2013) 0.90
Immunotherapy in the treatment of food allergy: focus on oral tolerance. Curr Opin Allergy Clin Immunol (2009) 0.89
Serological and clinical characteristics of children with peanut sensitization in an Asian community. Pediatr Allergy Immunol (2009) 0.88
Maternal and infant diets for prevention of allergic diseases: understanding menu changes in 2008. J Allergy Clin Immunol (2008) 0.88
Omalizumab : other indications and unanswered questions. Clin Rev Allergy Immunol (2005) 0.87
Peanut protein allergens: the effect of roasting on solubility and allergenicity. Int Arch Allergy Immunol (2004) 0.86
Food allergy education for school nurses: a needs assessment survey by the consortium of food allergy research. J Sch Nurs (2010) 0.85
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report. J Am Acad Dermatol (2011) 0.85
Pollen food syndrome: update on the allergens. Curr Allergy Asthma Rep (2008) 0.85
Single-tree nut immunotherapy attenuates allergic reactions in mice with hypersensitivity to multiple tree nuts. J Allergy Clin Immunol (2010) 0.85
Food allergies: prevalence, molecular characterization, and treatment/prevention strategies. Annu Rev Nutr (2006) 0.85
Animal models of food allergy. Curr Opin Allergy Clin Immunol (2002) 0.84
The future of food allergy therapeutics. Semin Immunopathol (2012) 0.84
Modification of peanut allergen Ara h 3: effects on IgE binding and T cell stimulation. Int Arch Allergy Immunol (2002) 0.84
Vaccine approaches for food allergy. Curr Top Microbiol Immunol (2011) 0.84
Occupational asthma symptoms and respiratory function among aerial pesticide applicators. Am J Ind Med (2003) 0.83
IgG and IgE avidity characteristics of peanut allergic individuals. Pediatr Allergy Immunol (2007) 0.83
Food allergy in children. Immunol Allergy Clin North Am (2005) 0.83
Food allergens. Clin Allergy Immunol (2008) 0.83
Novel strategy to create hypoallergenic peanut protein-polyphenol edible matrices for oral immunotherapy. J Agric Food Chem (2014) 0.83
Pepsinized cashew proteins are hypoallergenic and immunogenic and provide effective immunotherapy in mice with cashew allergy. J Allergy Clin Immunol (2012) 0.82
Clinical practice. Hymenoptera-sting hypersensitivity. N Engl J Med (2014) 0.82
Food allergy and asthma. Prim Care Respir J (2009) 0.82
Profiling families enrolled in food allergy immunotherapy studies. Pediatrics (2009) 0.82
Competitive inhibition ELISA for quantification of Ara h 1 and Ara h 2, the major allergens of peanuts. J AOAC Int (2005) 0.81
Oral desensitization for food hypersensitivity. Immunol Allergy Clin North Am (2011) 0.81
Pioneering immunotherapy for food allergy: clinical outcomes and modulation of the immune response. Immunol Res (2011) 0.80
Factoring PAF in anaphylaxis. N Engl J Med (2008) 0.80
Single-dose influenza vaccination of patients with egg allergy in a multicenter study. J Allergy Clin Immunol (2011) 0.79
Recent advances in the diagnosis and therapy of peanut allergy. Expert Rev Clin Immunol (2013) 0.79
Diacylglycerol kinase ζ deficiency in a non-CD4(+) T-cell compartment leads to increased peanut hypersensitivity. J Allergy Clin Immunol (2011) 0.78
Guidelines for the Diagnosis and Management of Food Allergy in the United States: summary of the NIAID-sponsored expert panel report. J Am Diet Assoc (2011) 0.78
Sensitization and allergic response and intervention therapy in animal models. J AOAC Int (2005) 0.78
Banana anaphylaxis with a negative commercial skin test. J Allergy Clin Immunol (2005) 0.78
Early peanut consumption: postpone or promote? J Allergy Clin Immunol (2009) 0.78
Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice. Mol Nutr Food Res (2013) 0.77
We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology. J Allergy Clin Immunol (2012) 0.77
Statement regarding "The public health benefits of air pollution control". J Allergy Clin Immunol (2012) 0.77